Los Angeles Business Journal

Valeant, Ackman Bid for Maker of Botox

Tuesday, April 22, 2014

Activist investor William Ackman and Valeant Pharmaceuticals revealed their offer to acquire Allergan, valuing the wrinkle treatment maker at about $46 billion, the Wall Street Journal reports.